BUY Fedbank Financial Services Ltd — ICICI Securities
byICICI SecuritiesHorizon: NA (inferred 1 year)29 Apr 2026via Institutional / Brokerage Research
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Long-term trend bullish — 200-day average rising over the past quarter
Technicals · trend·22 Oct · yesterday
Bajaj Consumer, Fedbank Financial In Focus After Q2 Results; ICICI Securities Sees Up To 46% Upside
NewsNdtv-Profit·16 Oct · 6d ago
Fedbank Financial Services reported strong Q2 FY27 results with a 63.1% YoY increase in Profit After Tax to ₹130.8 Cr and a 36.6% YoY growth in AUM to ₹22,035 Cr.
BSE · Company Update·15 Oct · 1w ago
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Fedbank Financial Services
- BUY — Kush Bohra7 Sept 2026 · ~2 weeks · target ₹172 · Expired
- BUY — Dhupesh Dhameja, SAMCO Securities5 Jun 2026 · ~3 months · target ₹175 · SL hit
- BUY — ICICI Securities29 Jul 2025 · ~1 year · target ₹150 · Target hit
- BUY — ICICI Securities24 Oct 2024 · ~1 year · target ₹130 · Target hit
- BUY — ICICI Securities1 May 2024 · ~1 year · target ₹184 · Expired
More from ICICI Securities
- BUY The Indian Hotels Company22 Oct 2026 · ~1 year · target ₹969 · Active
- BUY Just Dial21 Oct 2026 · ~1 year · target ₹850 · Active
- BUY Union Bank of India20 Oct 2026 · ~1 year · target ₹230 · Active
- BUY Rossari Biotech20 Oct 2026 · ~1 year · target ₹520 · Active
- BUY Tatva Chintan Pharma Chem20 Oct 2026 · ~1 year · target ₹2,385 · Active

